Micron, Nvidia, and the September Effect: What 98 Years of Data Say Investors Should Do
Axe Cap view
AI Infrastructure Spurs Selective Interest Amid September Volatility
Despite September’s historical market softness, Micron and Nvidia’s AI advances suggest selective tech investment opportunities with clear South African currency implications.
September has a notorious reputation for market dips, but relying on calendar quirks is a weak strategy. Instead, focus on substance. Micron (MU) and Nvidia (NVDA) are extending their leadership in AI infrastructure — Micron with its new HBM4 memory designed for faster, energy-efficient AI systems, and Nvidia unveiling the Vera Rubin platform that integrates computing and storage for next-gen AI workloads. These aren’t just flashy upgrades; they position both players well as AI’s backbone evolves. South African investors should watch USD/ZAR closely, as strength in these US tech giants could tighten the rand amid demand for dollars to access global tech stocks. On the JSE itself, tech exposure is limited; Prosus remains relevant but less directly tied to chip manufacturing innovation. The risk? AI hype fades without broader adoption, or a surprise semiconductor downturn. But ignoring these structural tech upgrades because it’s “September” would be a missed signal. this is just our opinion and not financial advice
We’d selectively buy USD/ZAR hedged exposure to US AI-related tech with a nod to Micron and Nvidia, while watching Prosus for any AI content play shifts. Avoid chasing September market timing and focus on fundamentals driving these infrastructure changes.
- USD/ZAR
- Prosus
- Broad AI adoption slows
- Semiconductor cycle downturn impacts earnings
6/10
While September historically shows weakness in stock markets, investors should focus on fundamentals rather than calendar patterns. Micron and Nvidia are advancing AI infrastructure with new products—Micron's HBM4 memory and storage solutions, and Nvidia's Vera Rubin platform—that position them well in the evolving AI build-out cycle. Both companies face risks but show strong competitive positioning.
Our take is based on reporting first published by The Motley Fool.
More stories like this
- Intapp Chief Product Officer Thad Jampol Sells 25,000 Shares
- BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?
- Tim Cook Grew Apple From a $350 Billion Company Into a Multi-Trillion-Dollar Giant Over Nearly 15 Years as CEO. Can John Ternus' Product-First Approach Extend That Compounding?